Oncolytic herpes simplex virus and radiation combination therapy results in a systemic immune response to inhibit neuroblastoma tumor growth

被引：0
|
作者：
Gillory, Lauren A. [1 ]
Megison, Michael L. [1 ]
Stewart, Jerry E. [1 ]
Nabers, Hugh C. [1 ]
Friedman, Gregory K. [1 ]
Markert, James M. [1 ]
Gillespie, G. Yancey [1 ]
Beierle, Elizabeth A. [1 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2012年 / 215卷 / 03期
关键词：
D O I：
10.1016/j.jamcollsurg.2012.06.192
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [1] Oncolytic herpes simplex virus for tumor therapy
    Hu, JCC
    Coffin, RS
    VIRAL VECTORS FOR TREATING DISEASES OF THE NERVOUS SYSTEM, 2003, 55 : 165 - 184
  • [2] Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma
    Saha, Dipongkor
    Martuza, Robert L.
    Rabkin, Samuel D.
    IMMUNOTHERAPY, 2018, 10 (09) : 779 - 786
  • [3] Oncolytic and immune effects of RAPTOR: a novel oncolytic Herpes Simplex Virus 1 expressing PTEN-L for brain tumor therapy
    Russell, Luke
    Sprague, Alexander
    Jaime-Ramirez, Alena Cristina
    Bolyard, Chelsea
    Banasavadi-Siddegowda, Yeshavanth
    Yoo, JiYoung
    Wang, Pin Yi
    Cripe, Timothy
    Kaur, Balveen
    CANCER RESEARCH, 2017, 77
  • [4] Development of a Regulatable Oncolytic Herpes Simplex Virus Type 1 Recombinant Virus for Tumor Therapy
    Yao, Feng
    Murakami, Nao
    Bleiziffer, Oliver
    Zhang, Pengwei
    Akhrameyeva, Natali V.
    Xu, Ximing
    Brans, Richard
    JOURNAL OF VIROLOGY, 2010, 84 (16) : 8163 - 8171
  • [5] ONCOLYTIC HERPES SIMPLEX VIRUS IMMUNOVIROTHERAPY IN COMBINATION WITH TIGIT IMMUNE CHECKPOINT BLOCKADE TO TREAT GLIOBLASTOMA
    Panagioti, Eleni
    Kelley, J.
    Goins, William F.
    Ligon, Keith
    Dixon, Karen
    Anderson, Ana
    Kuchroo, Vijay
    Chiocca, Antonio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A933 - A933
  • [6] Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy
    Jarnagin, WR
    Zager, JS
    Hezel, M
    Stanziale, SF
    Adusumilli, PS
    Gonen, M
    Ebright, MI
    Culliford, A
    Gusani, NJ
    Fong, Y
    CANCER GENE THERAPY, 2006, 13 (03) : 326 - 334
  • [7] Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy
    W R Jarnagin
    J S Zager
    M Hezel
    S F Stanziale
    P S Adusumilli
    M Gonen
    M I Ebright
    A Culliford
    N J Gusani
    Y Fong
    Cancer Gene Therapy, 2006, 13 : 326 - 334
  • [8] Enhancement of systemic tumor immunity for squamous cell carcinoma cells by an oncolytic herpes simplex virus
    Meshii, N.
    Takahashi, G.
    Okunaga, S.
    Hamada, M.
    Iwai, S.
    Takasu, A.
    Ogawa, Y.
    Yura, Y.
    CANCER GENE THERAPY, 2013, 20 (09) : 493 - 498
  • [9] Enhancement of systemic tumor immunity for squamous cell carcinoma cells by an oncolytic herpes simplex virus
    N Meshii
    G Takahashi
    S Okunaga
    M Hamada
    S Iwai
    A Takasu
    Y Ogawa
    Y Yura
    Cancer Gene Therapy, 2013, 20 : 493 - 498
  • [10] Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation
    Benencia, Fabian
    Courreges, Maria C.
    Fraser, Nigel W.
    Coukos, George
    CANCER BIOLOGY & THERAPY, 2008, 7 (08) : 1194 - 1205
12345